Sandoz And Aurobindo Cancel US Deal
Billion-Dollar US Oral Solids And Dermatology Deal Called Off
Sandoz and Aurobindo have mutually agreed to terminate their billion-dollar agreement that would have seen the Indian company acquire Sandoz’ dermatology and oral solids businesses in the US, citing a delay in FTC approval for the deal.
